Global Iopromide API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR102401640

Publication Date:

October 3, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Manufacturing (Automotive) [2]

Components [3]

Automotive [4]

Description:

The global Iopromide API market size was valued at USD 143 million in 2023 and is forecast to a readjusted size of USD 190.9 million by 2030 with a CAGR of 4.2% during review period.
Iopromide is an active pharmaceutical ingredient (API) used as an X-ray and CT scan contrast agent for medical imaging.
The market for Iopromide API is driven by the need for precise and accurate medical imaging in diagnostic procedures. Iopromide enhances the visibility of blood vessels and tissues, aiding in the diagnosis of various medical conditions. The demand for high-quality and reliable contrast agents contributes to the growth of this market.
This report includes an overview of the development of the Iopromide API industry chain, the market status of Hospitals (Original Drug, Generic Drug), Clinics (Original Drug, Generic Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Iopromide API.
Regionally, the report analyzes the Iopromide API markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Iopromide API market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Iopromide API market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Iopromide API industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Original Drug, Generic Drug).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Iopromide API market.
Regional Analysis: The report involves examining the Iopromide API market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Iopromide API market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Iopromide API:
Company Analysis: Report covers individual Iopromide API manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Iopromide API This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Iopromide API. It assesses the current state, advancements, and potential future developments in Iopromide API areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Iopromide API market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Iopromide API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Original Drug
Generic Drug
Market segment by Application
Hospitals
Clinics
Major players covered
Bayer
Stellite
Haichang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Iopromide API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Iopromide API, with price, sales, revenue and global market share of Iopromide API from 2019 to 2024.
Chapter 3, the Iopromide API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Iopromide API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Iopromide API market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Iopromide API.
Chapter 14 and 15, to describe Iopromide API sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope of Iopromide API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Iopromide API Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Original Drug
1.3.3 Generic Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Iopromide API Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.5 Global Iopromide API Market Size & Forecast
1.5.1 Global Iopromide API Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Iopromide API Sales Quantity (2019-2030)
1.5.3 Global Iopromide API Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Iopromide API Product and Services
2.1.4 Bayer Iopromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bayer Recent Developments/Updates
2.2 Stellite
2.2.1 Stellite Details
2.2.2 Stellite Major Business
2.2.3 Stellite Iopromide API Product and Services
2.2.4 Stellite Iopromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Stellite Recent Developments/Updates
2.3 Haichang Pharmaceutical
2.3.1 Haichang Pharmaceutical Details
2.3.2 Haichang Pharmaceutical Major Business
2.3.3 Haichang Pharmaceutical Iopromide API Product and Services
2.3.4 Haichang Pharmaceutical Iopromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Haichang Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Iopromide API by Manufacturer
3.1 Global Iopromide API Sales Quantity by Manufacturer (2019-2024)
3.2 Global Iopromide API Revenue by Manufacturer (2019-2024)
3.3 Global Iopromide API Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Iopromide API by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Iopromide API Manufacturer Market Share in 2023
3.4.2 Top 6 Iopromide API Manufacturer Market Share in 2023
3.5 Iopromide API Market: Overall Company Footprint Analysis
3.5.1 Iopromide API Market: Region Footprint
3.5.2 Iopromide API Market: Company Product Type Footprint
3.5.3 Iopromide API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Iopromide API Market Size by Region
4.1.1 Global Iopromide API Sales Quantity by Region (2019-2030)
4.1.2 Global Iopromide API Consumption Value by Region (2019-2030)
4.1.3 Global Iopromide API Average Price by Region (2019-2030)
4.2 North America Iopromide API Consumption Value (2019-2030)
4.3 Europe Iopromide API Consumption Value (2019-2030)
4.4 Asia-Pacific Iopromide API Consumption Value (2019-2030)
4.5 South America Iopromide API Consumption Value (2019-2030)
4.6 Middle East and Africa Iopromide API Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Iopromide API Sales Quantity by Type (2019-2030)
5.2 Global Iopromide API Consumption Value by Type (2019-2030)
5.3 Global Iopromide API Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Iopromide API Sales Quantity by Application (2019-2030)
6.2 Global Iopromide API Consumption Value by Application (2019-2030)
6.3 Global Iopromide API Average Price by Application (2019-2030)
7 North America
7.1 North America Iopromide API Sales Quantity by Type (2019-2030)
7.2 North America Iopromide API Sales Quantity by Application (2019-2030)
7.3 North America Iopromide API Market Size by Country
7.3.1 North America Iopromide API Sales Quantity by Country (2019-2030)
7.3.2 North America Iopromide API Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Iopromide API Sales Quantity by Type (2019-2030)
8.2 Europe Iopromide API Sales Quantity by Application (2019-2030)
8.3 Europe Iopromide API Market Size by Country
8.3.1 Europe Iopromide API Sales Quantity by Country (2019-2030)
8.3.2 Europe Iopromide API Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Iopromide API Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Iopromide API Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Iopromide API Market Size by Region
9.3.1 Asia-Pacific Iopromide API Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Iopromide API Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Iopromide API Sales Quantity by Type (2019-2030)
10.2 South America Iopromide API Sales Quantity by Application (2019-2030)
10.3 South America Iopromide API Market Size by Country
10.3.1 South America Iopromide API Sales Quantity by Country (2019-2030)
10.3.2 South America Iopromide API Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Iopromide API Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Iopromide API Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Iopromide API Market Size by Country
11.3.1 Middle East & Africa Iopromide API Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Iopromide API Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Iopromide API Market Drivers
12.2 Iopromide API Market Restraints
12.3 Iopromide API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Iopromide API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Iopromide API
13.3 Iopromide API Production Process
13.4 Iopromide API Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Iopromide API Typical Distributors
14.3 Iopromide API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Bayer
Stellite
Haichang Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂